The first Resmed trade was made in Q1 2013.
Since then Jeremy Grantham bought shares three more times and sold shares on nine occasions. The investor completely sold their stake between Q3 2014 and Q1 2016.
Avg closing price
Price range
Sold -37.3 Thousand shares
Q1 2016
Avg closing price
$56.60
Price range
$51.40
-
$60.36
Sold 48.5% shares (-35.2 Thousand shares)
Q4 2015
Avg closing price
$56.37
Price range
$51.25
-
$60.02
Sold 34.0% shares (-37.4 Thousand shares)
Q3 2015
Avg closing price
$53.83
Price range
$49.43
-
$57.95
Sold 0.7% shares (-800 shares)
Q2 2015
Avg closing price
$63.12
Price range
$55.44
-
$74.82
Sold 0.2% shares (-200 shares)
Q1 2015
Avg closing price
$64.95
Price range
$56.65
-
$72.44
Sold 17.7% shares (-23.8 Thousand shares)
Q4 2014
Avg closing price
$52.17
Price range
$46.25
-
$57.39
Sold 23.2% shares (-40.6 Thousand shares)
Q3 2014
Avg closing price
$50.96
Price range
$48.65
-
$53.35
Increased shares by 2.6% (+4.5 Thousand shares)
Q2 2014
Avg closing price
$49.56
Price range
$44.43
-
$53.76
Increased shares by 97.5% (+84.3 Thousand shares)
Q1 2014
Avg closing price
$44.92
Price range
$42.03
-
$47.82
Sold 0.4% shares (-329 shares)
Q4 2013
Avg closing price
$50.62
Price range
$45.36
-
$57.11
Increased shares by 39.2% (+24.5 Thousand shares)
Q3 2013